CURRICULUM VITAE

From FETAL PRECURSOR CELL TRANSPLANTATION (FPCT)
Jump to: navigation, search

MUDr. E. Michael Molnar, M.D., M.S., graduated summa cum laude, 4.0. grade average, from the Faculty of Medicine, Komensky University, Bratislava, Czechoslovakia. Following the invasion of Warsaw Pact armies into Czechoslovakia on August 21, 1968, he emigrated to the United States at the age of 26, already certified by the Czechoslovak Board of Head and Neck Surgery, and appointed a County Consultant for Pediatric Head & Neck Surgery.

 

Dr. Molnar repeated his residency training (1971-75) as required by US authorities. During this period he was an Assistant at A. Lincoln School of Medicine in Chicago, Ill., and a graduate student at the University of Illinois Medical Center, Chicago, Ill. In 1975 he was certified by the American Board of Head and Neck Surgery and received a Master of Science degree in physiology from the University of Illinois at the Medical Center in Chicago, Ill.

 

After 1975, Dr. Molnar developed a private practice of head & neck, and plastic & reconstructive surgery in Los Angeles. He was a Clinical Professor at C. Drew Medical School in Los Angeles, Calif. The news of horrible death of his father from complications of diabetes mellitus in 1976 caused Dr. Molnar to search for new treatments for incurable and no longer treatable diseases. This research culminated in a public educational campaign about such therapies. He published in 1984 in the U.S. the first book for general public about aging disease written by U.S. physician.

 

Unexpectedly, for a physician from Europe, such activities brought on severe attacks by the U.S. medical industry and Dr. Molnar decided to return to Europe in 1988 to pursue his research on fetal cell transplantation. In 1988, he obtained the approval of the Yugoslav authorities to organize a clinical research project which had to be stopped in 1990 due to the onset of civil war. So Dr. Molnar approached Prof. Dr. Chazov, U.S.S.R. Minister of Health, with a request to continue his work in the Soviet Union. Dr. Molnar was invited by him to Moscow in November 1989 to launch a very successful project on the use of cell transplantation as a treatment for a wide variety of incurable and no longer treatable diseases in cooperation with the 20 top Russian medical research institutes under the title ‘International Institute of Biological Medicine’..


Dr. Molnar is one of the few physicians with extensive experience in both animal and human fetal precursor cell transplantation, and qualified to warn against the dangers of human embryonic stem cell transplantation. Dr. Molnar explains in this textbook his preference for fetal precursor cell xeno-transplantation (animal fetal) over allo-transplantation (human fetal). Directly, or under Dr. Molnar’s supervision, 10,000 patients have been treated by various techniques of fetal precursor cell transplantation in the U.S.S.R./Russia, U.S.A., Germany, Italy, Switzerland, Czechoslovakia, Yugoslavia, Mexico, Malaysia, Thailand, Indonesia, Qatar, South Africa, Nigeria, Panama, Austria, Australia, India, Peoples’ Republic of China, Hong Kong, Macau. Besides these countries he lectured repeatedly on cell transplantation in Taiwan, South Korea, Cambodia, Kuwait, Egypt, Jordan, Dubai, Rumania, Republic of Georgia, Turkey, and visited with the Ministers of Health about cell transplantation in many other countries.

 

In September 1996, the U.S. FDA issued a draft of guidelines on the use of cell & tissue xeno-transplantation that made possible an official cooperation with U.S. FDA (Dec.’96). In 1998, Dr. Molnar set up the manufacturing of fetal precursor cell xeno-transplants, based on his U.S. patent application “Cell and Tissue Xenotransplants” and related know-how. In February 1999, four IND applications for the treatment of diabetic complications by cell transplantation of animal fetal origin, written by Dr. Molnar, were filed with U.S. FDA thereby establishing GMP rules for fetal precursor cell transplantation.
 
Dr. Molnar is Director (since 1989) of Bio-Cellular Research Organization of Stem Cell Transplantation Limited, the first and only manufacturer of fetal precursor cell xeno-transplants since 1998. He is very likely the world’s foremost expert on fetal precursor cell transplantation, the key component of successful treatment of incurable and no longer treatable diseases.


Six years ago Dr. Molnar was declared the ‘father of cell transplantation’ in Russia. More recently he became ‘father of fetal precursor cell transplantation’ in Asia, as the first lecturer on this subject in the majority of Asian countries.